Enhanced phosphorylation of p53 by ATN in response to DNA damage

被引:1695
作者
Banin, S
Moyal, L
Shieh, SY
Taya, Y
Anderson, CW
Chessa, L
Smorodinsky, NI
Prives, C
Reiss, Y
Shiloh, Y [1 ]
Ziv, Y
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Ramat Aviv, Israel
[2] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[3] Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, Tokyo 104, Japan
[4] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA
[5] Univ Rome La Sapienza, Dipartimento Med Sperimentale, I-00161 Rome, Italy
[6] Tel Aviv Univ, George S Wise Fac Life Sci, Hybridoma Unit, IL-69978 Ramat Aviv, Israel
[7] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel
关键词
D O I
10.1126/science.281.5383.1674
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ATM protein, encoded by the gene responsible for the human genetic disorder ataxia telangiectasia (A-T), regulates several cellular responses to DNA breaks. ATM shares a phosphoinositide 3-kinase-related domain with several proteins, some of them protein kinases. A wortmannin-sensitive protein kinase activity was associated with endogenous or recombinant ATM and was abolished by structural ATM mutations. In vitro substrates included the translation repressor PHAS-I and the p53 protein. ATM phosphorylated p53 in vitro on a single residue, serine-15, which is phosphorylated in vivo in response to DNA damage. This activity was markedly enhanced within minutes after treatment of cells with a radiomimetic drug; the total amount of ATM remained unchanged. Various damage-induced responses may be activated by enhancement of the protein kinase activity of ATM.
引用
收藏
页码:1674 / 1677
页数:4
相关论文
共 32 条
[1]  
BANIN S, UNPUB
[2]   Atm-deficient mice: A paradigm of ataxia telangiectasia [J].
Barlow, C ;
Hirotsune, S ;
Paylor, R ;
Liyanage, M ;
Eckhaus, M ;
Collins, F ;
Shiloh, Y ;
Crawley, JN ;
Ried, T ;
Tagle, D ;
WynshawBoris, A .
CELL, 1996, 86 (01) :159-171
[3]   CONTROL OF P70 S6 KINASE BY KINASE-ACTIVITY OF FRAP IN-VIVO [J].
BROWN, EJ ;
BEAL, PA ;
KEITH, CT ;
CHEN, J ;
SHIN, TB ;
SCHREIBER, SL .
NATURE, 1995, 377 (6548) :441-446
[4]   Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin [J].
Brunn, GJ ;
Hudson, CC ;
Sekulic, A ;
Williams, JM ;
Hosoi, H ;
Houghton, PJ ;
Lawrence, JC ;
Abraham, RT .
SCIENCE, 1997, 277 (5322) :99-101
[5]   Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002 [J].
Brunn, GJ ;
Williams, J ;
Sabers, C ;
Wiederrecht, G ;
Lawrence, JC ;
Abraham, RT .
EMBO JOURNAL, 1996, 15 (19) :5256-5267
[6]  
FISCELLA M, 1993, ONCOGENE, V8, P1519
[7]   Genotype-phenotype relationships in ataxia-telangiectasia and variants [J].
Gilad, S ;
Chessa, L ;
Khosravi, R ;
Russell, P ;
Galanty, Y ;
Piane, M ;
Gatti, RA ;
Jorgensen, TJ ;
Shiloh, Y ;
Bar-Shira, A .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :551-561
[8]   Predominance of null mutations in ataxia-telangiectasia [J].
Gilad, S ;
Khosravi, R ;
Shkedy, D ;
Uziel, T ;
Ziv, Y ;
Savitsky, K ;
Rotman, G ;
Smith, S ;
Chessa, L ;
Jorgensen, TJ ;
Harnik, R ;
Frydman, M ;
Sanal, O ;
Portnoi, S ;
Goldwicz, Z ;
Jaspers, NGJ ;
Gatti, RA ;
Lenoir, G ;
Lavin, MF ;
Tatsumi, K ;
Wegner, RD ;
Shiloh, Y ;
BarShira, A .
HUMAN MOLECULAR GENETICS, 1996, 5 (04) :433-439
[9]  
GOLDBERG IH, 1995, ENEDIYNE ANTIBIOTICS, P327
[10]   DNA-DEPENDENT PROTEIN-KINASE CATALYTIC SUBUNIT - A RELATIVE OF PHOSPHATIDYLINOSITOL 3-KINASE AND THE ATAXIA-TELANGIECTASIA GENE-PRODUCT [J].
HARTLEY, KO ;
GELL, D ;
SMITH, GCM ;
ZHANG, H ;
DIVECHA, N ;
CONNELLY, MA ;
ADMON, A ;
LEESMILLER, SP ;
ANDERSON, CW ;
JACKSON, SP .
CELL, 1995, 82 (05) :849-856